Gilead pulls drug for bladder cancer after trial failure

The latest stories trending on MedCity News.

Editor's Pick

Top Story Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure Gilead Sciences' Trodelvy did not meet the main overall survival goal of its confirmatory Phase 3 test. The antibody drug conjugate was awarded accelerated approval for advanced urothelial carcinoma in 2021. Announcement Join MedCity News at ENGAGE at HLTH forum on Sunday!! MedCity will be hosting three panels entitled ENGAGE at HLTH on October 20 during HLTH. Venue: Evergreen Stage, Time: 9:30 - 12:00 p.m. One panel will explore the following topic: 10:15 - 11:15 a.m Reproductive Care is Not Just About Pregnancy and Mother's Health Moderator: Arundhati Parmar, Editor-in-Chief, MedCity News  Speakers: Atul Grover, Executive Director, Research & Action Institute, Association of American Medical Colleges (AAMC) Dr. Irene Agostini, Former CMO, CMO-Liaison, University of New Mexico Hospital Dr. Robbie Harriford, Chief Medical Officer, Samuel L. Rodgers Health Center Click here to register today!

Featured News

New Study Shows That Waymark Reduces ED, Hospital Visits for Medicaid Patients Waymark's community-based interventions reduce hospital and emergency department visits and improve care quality, according to a new study. The company supports Medicaid patients by connecting them with community health workers, therapists, pharmacists and care coordinators in their area. Nearly 7,000 US Healthcare Devices & Records Are Exposed to the Public Internet, Research Shows New research shows that there are more than 14,000 unique IP addresses across the globe exposing patients' potentially sensitive medical information on the public internet. Nearly half of these exposures are in the U.S. Overcoming Pharma's Major Pain Points and Pitfalls With AI This technological shift not only boosts efficiency and profitability for pharmaceutical companies but also speeds up the delivery of innovative therapies to patients. Unify Digital Publishing with MLR Review to Speed Compliant Content to Market Organizations are delivering digital experiences and content to HCPs on a much larger scale than was previously possible. Integrating digital tools will advance things even further and help marketers and MLR teams maintain brand consistency and ensure compliance across digital and content operations.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 9 In this episode, we talk about virtual care and how Dr. Eve Cunningham approaches technology to scale remote care programs to help physicians managing chronic disease patients. We also address how the Federal Trade Commission is suing the three largest pharmacy benefit managers for their role in keeping insulin prices high when lower priced insulin was already available. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe